deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT02444572

Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® (ENOXACARE)

Comparison of Thromboembolic Events in Patients Undergoing Gastrointestinal Cancer Surgery and Thromboprophylactic Treatment With Two Enoxaparin Formulations (ENOXA® vs Lovenox®)

Sponsor: Les Laboratoires des Médicaments Stériles

Conditions Gastrointestinal Neoplasms Thromboembolic Event
Interventions Enoxaparin 4000 IU
Updated 12 times since 2017 Last updated: Jul 27, 2021 Started: Oct 31, 2015 Primary completion: Jul 31, 2020 Completion: Jul 10, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Gastrointestinal Neoplasms and Thromboembolic Event, this trial is completed. The trial is conducted by Les Laboratoires des Médicaments Stériles and has accumulated 12 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2018 · 13 months · monthly snapshotRecruiting~Feb 2018 – ~Mar 2018 · 28 days · monthly snapshotUnknown Status~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotRecruiting~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotRecruiting~Sep 2018 – ~Dec 2018 · 3 months · monthly snapshotRecruiting~Dec 2018 – ~Jan 2020 · 13 months · monthly snapshotRecruiting~Jan 2020 – ~Mar 2020 · 2 months · monthly snapshotRecruiting~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshotRecruiting~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshotRecruiting~Sep 2021 – ~Jul 2024 · 34 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 21 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Sep 2021 — Jul 2024 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

  4. Jan 2021 — Sep 2021 [monthly]

    Recruiting PHASE4

  5. Mar 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

▶ Show 7 earlier versions

  1. Jan 2020 — Mar 2020 [monthly]

    Recruiting PHASE4

  2. Dec 2018 — Jan 2020 [monthly]

    Recruiting PHASE4

  3. Sep 2018 — Dec 2018 [monthly]

    Recruiting PHASE4

  4. Jun 2018 — Sep 2018 [monthly]

    Recruiting PHASE4

  5. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE4

    Status: Unknown Status → Recruiting

  6. Feb 2018 — Mar 2018 [monthly]

    Unknown Status PHASE4

    Status: Recruiting → Unknown Status

  7. Jan 2017 — Feb 2018 [monthly]

    Recruiting PHASE4

    First recorded

Oct 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Les Laboratoires des Médicaments Stériles
Data source: Les Laboratoires des Médicaments Stériles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations